SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-21-009249
Filing Date
2021-02-16
Accepted
2021-02-16 07:31:33
Documents
1
Group Members
PONTIFAX 5 G.P. L.P.PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea135712-13gnussbaum_pieris.htm SC 13G 163329
  Complete submission text file 0001213900-21-009249.txt   164809
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88917 | Film No.: 21632455
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G